The company's liquidity buffer is under significant pressure, with cash reserves falling from $124.2 million in 2025Q4 to $73.6 million in 2026Q1, despite maintaining a modest debt-to-equity ratio of 0.12.
| Total Current Assets | 258.2M | 267.95M | 203.01M | 146.74M | 199.7M | 318.23M | 220.72M | 139.58M | 29.56M | 26.73M |
| Cash & Short-Term Investments | 233.22M | 239.95M | 185.01M | 114.18M | 167.66M | 287.06M | 203.29M | 128.29M | 19.74M | 22.62M |
| Cash Only | 73.59M | 124.25M | 91.42M | 56.98M | 89.13M | 105.58M | 68.53M | 55.05M | 19.74M | 22.62M |
| Short-Term Investments | 159.62M | 115.71M | 93.59M | 57.2M | 78.53M | 181.48M | 134.76M | 73.24M | 0 | 0 |
| Accounts Receivable | 13.02M | 16.2M | 8.14M | 17.73M | 16.64M | 18.47M | 6.35M | 3.3M | 4.46M | 1.94M |
| Days Sales Outstanding | 75.75 | - | 35.11 | 88.07 | 93.38 | 78.85 | 29.47 | 18.47 | 43.07 | 75.27 |
| Inventory | 6.93M | 6.14M | 3.98M | 5.66M | 6.38M | 4.08M | 2.67M | 1.42M | 2.13M | 822K |
| Days Inventory Outstanding | 35.03 | 41.63 | 25.11 | 37.38 | 45.07 | 27.67 | 16.68 | 12.05 | 29.99 | 25.56 |
| Other Current Assets | 5.03M | 5.65M | 5.89M | 9.17M | 9.02M | 1.53M | 2.96M | 3.18M | 1.3M | 542K |
| Total Non-Current Assets | 67.2M | 66.21M | 67.25M | 78.36M | 93M | 78.3M | 24.12M | 17.71M | 12.11M | 6.84M |
| Property, Plant & Equipment | 63.4M | 59.93M | 64.73M | 75.22M | 88.42M | 73.47M | 22.11M | 15.95M | 11.45M | 6.34M |
| Fixed Asset Turnover | 1.04x | - | 1.31x | 0.98x | 0.74x | 1.16x | 3.56x | 4.09x | 3.30x | 1.48x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.8M | 6.28M | 2.53M | 3.14M | 4.59M | 4.83M | 2.02M | 1.76M | 659K | 495K |
| Total Assets | 325.39M | 334.16M | 270.27M | 225.1M | 292.7M | 396.53M | 244.84M | 157.29M | 41.67M | 33.56M |
| Asset Turnover | 0.22x | - | 0.31x | 0.33x | 0.22x | 0.22x | 0.32x | 0.41x | 0.91x | 0.28x |
| Asset Growth % | 83.38% | 23.64% | 20.07% | -23.1% | -26.18% | 61.95% | 55.66% | 277.47% | 24.15% | - |
| Total Current Liabilities | 39.05M | 39.63M | 31.13M | 47.23M | 33.13M | 31.31M | 40.64M | 49.96M | 57.85M | 48.99M |
| Accounts Payable | 12.68M | 12.99M | 6.4M | 14.92M | 12.85M | 9.22M | 8.3M | 7.34M | 6.57M | 4.04M |
| Days Payables Outstanding | 76.62 | 88.01 | 40.4 | 98.53 | 90.75 | 62.52 | 51.76 | 62.1 | 92.27 | 125.49 |
| Short-Term Debt | 0 | 0 | 1.67M | 1.65M | 2.22M | 1.81M | 0 | 0 | 5M | 17.51M |
| Deferred Revenue (Current) | 1.63M | 0 | 3.1M | 3.29M | 1.29M | 4.36M | 21.03M | 35.98M | 42.9M | 24.71M |
| Other Current Liabilities | 26.37M | 26.64M | 10.86M | 19.62M | 9.55M | 11.19M | 8.45M | 4.39M | 43.18M | 718K |
| Current Ratio | 6.61x | 6.76x | 6.52x | 3.11x | 6.03x | 10.16x | 5.43x | 2.79x | 0.51x | 0.55x |
| Quick Ratio | 6.44x | 6.61x | 6.39x | 2.99x | 5.83x | 10.03x | 5.37x | 2.77x | 0.47x | 0.53x |
| Cash Conversion Cycle | 34.16 | - | 19.82 | 26.93 | 47.7 | 44 | -5.62 | -31.57 | -19.21 | -24.66 |
| Total Non-Current Liabilities | 31.59M | 33.35M | 36.19M | 48.42M | 41.43M | 54.91M | 9.26M | 639K | 90.21M | 77.18M |
| Long-Term Debt | 31.02M | 31.87M | 0 | 0 | 0 | 0 | 0 | 0 | 683K | 292K |
| Capital Lease Obligations | 66.05M | 0 | 34.88M | 38.32M | 41.04M | 52.8M | 8.54M | 639K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 562K | 1.48M | 1.3M | 10.1M | 389K | 2.12M | 720K | 0 | 89.53M | 76.89M |
| Total Liabilities | 70.63M | 72.98M | 67.31M | 95.66M | 74.56M | 86.23M | 49.9M | 50.6M | 148.06M | 126.17M |
| Total Debt | 31.02M | 31.87M | 44.25M | 47.73M | 48.65M | 58.33M | 10.99M | 2M | 5M | 17.51M |
| Net Debt | -42.57M | -92.38M | -47.17M | -9.26M | -40.48M | -47.25M | -57.54M | -53.05M | -14.75M | -5.11M |
| Debt / Equity | 0.12x | 0.12x | 0.22x | 0.37x | 0.22x | 0.19x | 0.06x | 0.02x | - | - |
| Debt / EBITDA | -0.33x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.46x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -609.71x | -395.34x | -3385.08x | -982.75x | -562.56x | -353.41x | -20610.50x | -21.13x | -9.50x | -17.11x |
| Total Equity | 254.76M | 261.19M | 202.96M | 129.44M | 218.14M | 310.3M | 194.94M | 106.69M | -106.39M | -92.6M |
| Equity Growth % | 124.32% | 28.69% | 56.79% | -40.66% | -29.7% | 59.17% | 82.72% | 200.28% | -14.89% | - |
| Book Value per Share | 2.45 | 2.93 | 3.43 | 2.69 | 4.77 | 7.07 | 5.67 | 5.92 | -4.89 | -4.26 |
| Total Shareholders' Equity | 254.76M | 261.19M | 202.96M | 129.44M | 218.14M | 310.3M | 194.94M | 106.69M | -106.39M | -92.6M |
| Common Stock | 10K | 10K | 9K | 5K | 5K | 4K | 4K | 3K | 1K | 1K |
| Retained Earnings | -661.29M | -631.26M | -549.99M | -468.71M | -360.41M | -247.09M | -181.87M | -140.59M | -115.5M | -95.62M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.13M | -3.02M |
| Accumulated OCI | -70K | 104K | -23K | -222K | -912K | -166K | 22K | -6K | -15K | -10K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and capital exhaustion
As reported in recent financial filings, Personalis has seen its total equity decline from $261.2 million in 2025Q4 to $254.8 million in 2026Q1, a trend that reflects the persistent accumulation of retained losses and underscores a weakening balance sheet trajectory as the company struggles to reach scale.
The consistent expansion of the accumulated deficit, now reaching $661.3 million, suggests that the company's business model has yet to achieve the necessary operating leverage to offset its high fixed-cost base. Investors should monitor whether this erosion of equity continues to outpace potential capital raises, as it may indicate a narrowing window for the company to achieve commercial viability.
According to the latest quarterly balance sheet, the company maintains a debt-to-equity ratio of 0.12, a figure that appears deceptively low given the underlying cash burn and the limited operational flexibility inherent in the current capital structure as reported in recent SEC filings.
While the absolute debt level of $31.0 million is relatively small, the company's inability to generate positive operating cash flow makes even this modest leverage a potential burden on liquidity. The reliance on debt in a pre-profit state warrants caution, as it may limit the company's ability to secure additional financing on favorable terms if the current cash burn persists.
Based on the provided financial data, cash reserves dropped sharply from $124.2 million in 2025Q4 to $73.6 million in 2026Q1, indicating a rapid depletion of the company's primary liquidity buffer that may necessitate further capital market activity to sustain ongoing research and development operations.
Although the current ratio of 6.61 appears robust on the surface, this metric is heavily influenced by the composition of current assets and does not account for the high cash-burn rate observed in recent quarters. The significant decline in cash over a single quarter suggests that the company's runway is shortening, which may force management to prioritize capital preservation over strategic growth initiatives.
As evidenced by the balance sheet, the company's asset base is heavily concentrated in property, plant, and equipment, with $63.4 million in net PPE, which may represent a significant impairment risk if the company fails to achieve the projected utilization rates for its sequencing infrastructure.
The lack of goodwill on the balance sheet is a positive indicator of conservative accounting, yet the high concentration of fixed assets in a contracting revenue environment suggests that these assets may be underutilized. Investors should consider the potential for future asset write-downs if the transition to clinical diagnostics does not materialize as expected, which would further impair the company's book value.
Quick answers to the most common questions about buying PSNL stock.
As of 2025, Personalis, Inc. (PSNL) had total assets of $334.2M including $268.0M in current assets.
Personalis, Inc. (PSNL) carries total debt of $31.9M, offset by $240.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Personalis, Inc. (PSNL) has total shareholders' equity (book value) of $261.2M ($2.93 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Personalis, Inc. (PSNL) reported a current ratio of 6.76x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.